drugset
Drugs / BK CTL
last change Jul 2020 re-read 3 minutes ago

BK CTL

also known as BK specific CTLs

Cell therapy

Developed for
viral infectious disease
Investigated by
Children's Hospital of Philadelphia · Johns Hopkins University · Medical College of Wisconsin · Nationwide Children's Hospital · New York Medical College · University of California, San Francisco

Trials 1

today NCT04197596 · Ph 1/2
2021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT04197596 Jul 2020 → Dec 2026 expected inborn error of immunity, viral infectious disease New York Medical College Recruiting No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BK CTL ClinicalTrials.gov intervention name — accepted as the source's own label NCT04197596 ↗
Known as BK specific CTLs “BK specific CTLs (2.5 x 104 CD3/kg) infused intravenously on day 0” NCT04197596 ↗
Modality Cell therapy “BK cytotoxic T cells (CTLs)” NCT04197596 ↗
Route Intravenous “BK specific CTLs (2.5 x 104 CD3/kg) infused intravenously on day 0” NCT04197596 ↗